ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,204.61
0.67%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.709
-0.04%
Brent Oil
82.435
-0.18%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Zosano Pharma Corporation (ZSAN)

  7. Zosano Pharma Corporation (ZSAN) ニュース

ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ZSAN
日付受信時刻ニュースソース見出しコード企業名
2022/07/2000 : 48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ZSANZosano Pharma Corporation
2022/06/0808 : 39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
2022/06/0808 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
2022/06/0221 : 36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/06/0221 : 00GlobeNewswire Inc.Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11NASDAQ:ZSANZosano Pharma Corporation
2022/05/1821 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/05/1405 : 17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZSANZosano Pharma Corporation
2022/05/1405 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/05/1405 : 00GlobeNewswire Inc.Zosano Pharma Reports First Quarter 2022 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
2022/05/0606 : 11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/04/3005 : 02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ZSANZosano Pharma Corporation
2022/04/3005 : 00GlobeNewswire Inc.Zosano Pharma Provides Corporate UpdateNASDAQ:ZSANZosano Pharma Corporation
2022/04/1121 : 00GlobeNewswire Inc.Zosano Pharma Announces Reverse Stock Split Effective TodayNASDAQ:ZSANZosano Pharma Corporation
2022/04/0205 : 22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZSANZosano Pharma Corporation
2022/03/2220 : 46TipRanksMaxim Group Thinks Zosano Pharma’s Stock is Going to RecoverNASDAQ:ZSANZosano Pharma Corporation
2022/03/1805 : 09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/03/1805 : 05GlobeNewswire Inc.Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
2022/02/1420 : 19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZSANZosano Pharma Corporation
2022/02/1207 : 31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZSANZosano Pharma Corporation
2022/02/1007 : 22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/02/1007 : 16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
2022/02/0911 : 55GlobeNewswire Inc.Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
2022/02/0906 : 18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
2022/02/0906 : 10GlobeNewswire Inc.Zosano Pharma Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
2022/01/2422 : 20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/01/0602 : 01GlobeNewswire Inc.CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
2022/01/0523 : 22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2022/01/0523 : 20GlobeNewswire Inc.Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
2021/12/1406 : 32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
2021/12/1406 : 30GlobeNewswire Inc.Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. YangNASDAQ:ZSANZosano Pharma Corporation
 Showing the most relevant articles for your search:NASDAQ:ZSAN

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
NYSE
CVX
Chevron
CCOM
US500
US 500
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
PM
XAUUSD
Gold vs US Dollar
NASDAQ
TSLA
Tesla
COIN
BTCUSD
Bitcoin
USOTC
RHHBY
Roche (QX)
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有